Merit Medical Systems (MMSI) Scheduled to Post Earnings on Tuesday

Merit Medical Systems (NASDAQ:MMSI) is set to post its quarterly earnings results after the market closes on Tuesday, April 23rd. Analysts expect Merit Medical Systems to post earnings of $0.36 per share for the quarter. Merit Medical Systems has set its FY 2019 guidance at $1.97-2.08 EPS and its FY19 guidance at $1.97-2.08 EPS.Individual that are interested in participating in the company’s earnings conference call can do so using this link.

Merit Medical Systems (NASDAQ:MMSI) last announced its earnings results on Tuesday, February 26th. The medical instruments supplier reported $0.48 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.45 by $0.03. Merit Medical Systems had a return on equity of 11.26% and a net margin of 4.76%. The firm had revenue of $232.25 million during the quarter, compared to analysts’ expectations of $231.03 million. During the same period in the prior year, the firm earned $0.33 EPS. The business’s revenue was up 21.7% on a year-over-year basis. On average, analysts expect Merit Medical Systems to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Merit Medical Systems stock opened at $57.66 on Monday. Merit Medical Systems has a twelve month low of $44.05 and a twelve month high of $66.34. The company has a quick ratio of 1.32, a current ratio of 2.45 and a debt-to-equity ratio of 0.40. The company has a market cap of $3.17 billion, a price-to-earnings ratio of 34.12, a P/E/G ratio of 2.47 and a beta of 1.11.

A number of analysts have weighed in on MMSI shares. Zacks Investment Research cut Merit Medical Systems from a “buy” rating to a “hold” rating in a research report on Monday, December 31st. BidaskClub cut Merit Medical Systems from a “strong-buy” rating to a “buy” rating in a research report on Saturday, January 5th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. Merit Medical Systems currently has a consensus rating of “Buy” and a consensus price target of $67.60.

In other news, Director Franklin J. Miller sold 20,000 shares of the stock in a transaction that occurred on Thursday, March 14th. The stock was sold at an average price of $60.44, for a total transaction of $1,208,800.00. Following the completion of the transaction, the director now directly owns 34,038 shares of the company’s stock, valued at approximately $2,057,256.72. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Michael E. Stillabower sold 10,000 shares of the stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $58.05, for a total value of $580,500.00. Following the transaction, the director now directly owns 63,618 shares of the company’s stock, valued at $3,693,024.90. The disclosure for this sale can be found here. Insiders have sold a total of 41,216 shares of company stock valued at $2,465,617 over the last ninety days. 5.16% of the stock is owned by insiders.

ILLEGAL ACTIVITY NOTICE: “Merit Medical Systems (MMSI) Scheduled to Post Earnings on Tuesday” was originally reported by Baseball Daily News and is owned by of Baseball Daily News. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.baseballdailydigest.com/news/2019/04/22/merit-medical-systems-mmsi-scheduled-to-post-earnings-on-tuesday.html.

About Merit Medical Systems

Merit Medical Systems, Inc manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides peripheral intervention products, including access, angiography, intervention, and drainage and biopsy for diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, and electrophysiology and cardiac rhythm management products to treat various heart conditions.

Further Reading: What is the formula for calculating total return?

Earnings History for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.